Britz Lab

6869

Citations

44

h-index

About Our Lab

The Cerebrovascular Research Laboratory studies brain microcirculation in normal and pathological conditions. The brain is critically dependent on a continuous and adequate blood supply for normal functioning, so such catastrophic events like stroke or subarachnoid hemorrhage not only damage the brain, but they lead to abnormalities of cerebrovascular circulation which may aggravate the consequences of the perpetrating event. 

 

Some of the changes in cerebrovascular circulation, however, could be beneficial. In our research, we study the mechanisms that lead to changes in cerebrovascular circulation following the initial insult. We explore which changes in microvascular circulation could actually be beneficial for the following recovery and which have a negative effect on the recovery. We also investigate the mechanisms by which abnormalities of cerebrovascular circulation damage the brain.

 

In our studies, we employ various in vitro and in vivo techniques to better understand the intimate relations between the initial causes, the changes in microcirculation and the role of the latter in brain damage. The ultimate goal of our studies is to develop new therapeutic approaches for the treatment of various neurological disturbances related to cerebrovascular circulation.

 

Projects & Highlights

 
The Cerebrovascular Research Laboratory studies brain circulation in normal and pathological conditions. For normal functioning the brain is critically dependent on a continuous and adequate blood supply. Brain circulation abnormalities, acute, like stroke or subarachnoid hemorrhage, or chronic, like vascular dementia, lead to long-lasting or permanent brain damage. The Cerebrovascular Research Laboratory explores physiology and pathophysiology of brain circulation in search of new therapeutic approaches to brain pathologies related to brain circulation. Using multidisciplinary approaches and the Cerebrovascular Research Lab studies: 

 

  • Hemorrhagic and ischemic strokes
  • Subarachnoid hemorrhage
  • Neuroprotection
  • Traumatic brain injury
  • Hemorragic and Ischemic Strokes

In spite of significant efforts to find new therapies, hemorrhagic and ischemic strokes remain in the top 10 causes of long term disability. The Cerebrovascular Research Laboratory is exploring innovative approaches developed in our Laboratory to the preservation of brain tissue following the catastrophic events using neuromodulation and “electroceuticals” tools to activate innate neuroprotective mechanisms. The Laboratory also collaborates with the Neuroregeneration laboratory to explore potential of stem cell therapy to recover damaged brain tissue.


Subarachnoid Hemorrhage

Subarachnoid hemorrhage, the catastrophic event resulting from the rupture of brain aneurism and traumatic damage of large brain surface arteries, leads to long-term or permanent brain damage. One of the factors leading to the long-term brain damage is abnormalities of cerebrospinal fluid flow, which interrupts normal clearance of brain parenchyma from various waste products. In our Laboratory we are exploring the role of innate brain coagulation system in the control of hemorrhage and regulation of cerebral fluid flow. This innovative approach will potentially lead to the development of new therapeutic approaches for the treatment of subarachnoid hemorrhage consequences. 

Neuroprotection

Brain is very delicate and depends on the stable continuous supply of oxygen and glucose provided by brain circulation. The complex system has evolved to protect the brain against damage due to inadequate supply of these major elements. This system includes regulation of cerebrovascular flow and the innate neuroprotective mechanisms. This system is activated naturally, for example, during diving or hibernation. Our Laboratory explores methods to protect the brain in various damaging conditions using innovative neuromodulation and electroceuticals approaches.

Traumatic Brain Injury

Traumatic brain injury presents a significant problem for military and civil population. Finding a treatment for this detrimental condition remains a serious challenge. Our Laboratory is developing new ground-breaking neuromodulatory approaches to address this problem. 

Research News
doctor holding a tablet with a chest scan on it's screen
Personalized Treatment Strategies for Lung Cancer
Houston Methodist researchers identified a novel and innovative marker to guide Immune Checkpoint Inhibitor Therapy for Lung Cancer.
woman sitting on an examination table in a doctor's office
Trailblazing New Perspectives: Treating Gynecological Cancers
The goal of this new study was to evaluate the feasibility of a phase three, multi-center randomized clinical trial comparing the efficacy of minimally invasive surgery with that of the traditional open method approach (laparotomy) in treating epithelial ovarian cancer.
arm in blood pressure testing machine
Getting to the Heart of Hypertension Disparities
Researchers address social risk factors for high blood pressure through a national study.
Evolving Treatment Beyond Pharmaceuticals
First-of-its-Kind Study Explores Novel Prescription Digital Therapeutic
An Unusual Presentation of Glioblastoma
Andrew Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, recently published one of the first-ever reported cases of progressive vision loss as the presenting manifestation of recurrent GBM with secondary LMS to the optic chiasm.
Engaging T cell Exhaustion for Solid Tumor Immunotherapies
Houston Methodist researchers investigated T cell exhaustion in murine models of prostate cancer and melanoma to explore possible advancements in immunotherapies for solid tumors.
Fighting a Deadly Duo
Investigating therapeutics to fight deadly TB/HIV coinfections.
Houston Methodist, Rice University launch groundbreaking Digital Health Institute
This initiative builds on ongoing collaborations between Houston Methodist and Rice University to transform the future of health care.
Stage I Nodal Marginal Zone Lymphoma Treatment Landscape
Houston Methodist researchers compared systemic therapy and radiation therapy in Stage I Nodal Marginal Zone Lymphoma Patients
2024 Digital Health Workshop Seed Fund Award Winners Announced
Houston Methodist researchers and their collaborators from Rice University have been awarded grants from the 2024 PATHS-UP Digital Health Workshop.
Pilot Study Offers Insight Into Alzheimer’s Research Participants Perceptions and Self-Efficacy
In a Houston Methodist study, Alzheimer’s disease research participants showed a high interest in genetic testing and provided valuable insights that can improve how test results are disclosed.
Breast Cancer Cells
Nanomedicine Makes Big Strides in the Fight Against Breast Cancer
Researchers deliver immunotherapy directly into triple-negative breast cancer tumors with nanofluidic implants, achieving tunable and sustained dosing of immunotherapeutics with high anti-tumor activity.
headshot of Constance Mobley smiling
Liver Failure Avengers Houston Methodist Researchers First in World
Under the leadership of Constance Mobley, MD, PhD, FACS, researchers have successfully performed a first-in-human miniature liver hepatocyte transplant to change a patient’s lymph nodes into ectopic miniature livers.
Predicting the Future of Cancer Treatment

Houston Methodist faculty developed a multiscale mechanistic model to further investigate the role of miR-155 in non-small cell lung cancer and predict clinical efficacy based on preclinical data.

Taking a Closer Look at West Nile Neuroimaging

A case report reviewing West Nile neuroinvasive disease imaging characteristics and the differential diagnosis of acute leukoencephalopathy highlights the usefulness of neuroimaging in WNND diagnosis in the absence of CSF markers.

Ending Organ Transplant Rejection

Studies at Houston Methodist suggest a novel strategy that may potentially eliminate or diminish transplant rejection, autoimmune diseases, and the need for immunosuppressive drugs

Location, Location, Location is Key to Pancreatic Cancer Prognosis

Molecular alterations found in pancreatic ductal adenocarcinoma samples may have potential therapeutic implications

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now